Neoadjuvant therapy in cancer treatment
Edward L. Trimble(Memorial Sloan Kettering Cancer Center), Michael Friedman(National Cancer Institute), Malcolm A. Smith(National Cancer Institute), C. L. Carter(Emmes (United States)), Richard Kaplan(University College London), Jeffrey Abrams(National Cancer Institute), Ellen G. Feigal(National Cancer Institute), Richard S. Ungerleider(Unknown)
Cited by 69
Related Papers
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914
How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment Trials
|Journal of Clinical Oncology|2002|531
Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients
|JNCI Journal of the National Cancer Institute|2006|415
The genomic landscape of pediatric acute lymphoblastic leukemia
|Nature Genetics|2022|394